Dysregulation of gene expression within the peroxisome proliferator activated receptor pathway in morbidly obese patients

By Hindle A.   Koury Jadd   McCaffrey Tim   Fu Sidney   Brody Fred  

Surgical Endoscopy, Vol. 23, Iss. 6, 2009-06 ,pp. : 1292-1297

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ gene polymorphisms and Crohn’s disease

By Leung Euphemia   Hong Jiwon   Fraser Alan   Merriman Tony   Vishnu Prakash   Krissansen Geoffrey  

International Journal of Colorectal Disease, Vol. 22, Iss. 4, 2007-04 ,pp. : 453-454

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Ghrelin Expression in the Gastric Mucosa of Morbidly Obese Patients

By Miyazaki Yasuhiro   Takiguchi Shuji   Seki Yosuke   Kasama Kazunori   Takahashi Tsuyoshi   Kurokawa Yukinori   Yamasaki Makoto   Miyata Hiroshi   Nakajima Kiyokazu   Mori Masaki   Doki Yuichiro  

World Journal of Surgery, Vol. 37, Iss. 12, 2013-12 ,pp. : 2883-2890

Springer Publishing Company

Access to resources Recommend Favorite

Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats

By Ozbek Emin  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 579-587

Springer Publishing Company

Access to resources Recommend Favorite

Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists

By Hase T.   Yoshimura R.   Mitsuhashi M.   Segawa Y.   Kawahito Y.   Wada S.   Nakatani T.   Sano H.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 542-547

Elsevier

Access to resources Recommend Favorite